首页> 外国专利> Coronary vasodilator controlled release dipyridamole compsn. - comprises film coated granules giving reduced side effects and also showing angina pectoris suppressing action

Coronary vasodilator controlled release dipyridamole compsn. - comprises film coated granules giving reduced side effects and also showing angina pectoris suppressing action

机译:冠状动脉扩张药控释双嘧达莫复合物。 -包含薄膜包衣的颗粒,可减少副作用并显示心绞痛抑制作用

摘要

coronary vasodilator compsn. comprising granules, not more than 2mm. in dia. of dipyridamole enclosed in a film, insoluble or only slightly soluble in water at 37 degrees C, which swells in contact with water and is degradable by man. The compsn. shows reduced side-effects such as headache, intestinal disorders and dizziness and also suppresses angina pectoris. Pref. film thickness is 0.1-200 mu m. When the interior of the granule comprises dipyridamol alone, it is to a concn. of 60-95%. It is pref. deposited on a biodegradable carrier such as starch, protein and esp. paraffins and stearin. Suitable film-formers are gelatin, ethylcellulose, polyvinyl alcohols, polyvinylpyrrolidone, polyamides etc. Pref. release time of the dipyridamol is 4-8 hr.
机译:冠状血管扩张剂包含不超过2mm的颗粒。在印度。的双嘧达莫包封在薄膜中,在37摄氏度时不溶于水或仅微溶于水,与水接触后溶胀,可由人降解。该compsn。显示出减少的副作用,如头痛,肠道疾病和头晕,还可以抑制心绞痛。首选膜厚度为0.1-200μm。当颗粒的内部仅包含潘生丁时,它就是浓缩物。 60-95%。好。沉积在可生物降解的载体上,例如淀粉,蛋白质和esp。石蜡和硬脂精。合适的成膜剂是明胶,乙基纤维素,聚乙烯醇,聚乙烯吡咯烷酮,聚酰胺等。双嘧达莫的释放时间为4-8小时。

著录项

  • 公开/公告号FR2353285A1

    专利类型

  • 公开/公告日1977-12-30

    原文格式PDF

  • 申请/专利权人 DOMS LABORATOIRES;

    申请/专利号FR19750028462

  • 发明设计人

    申请日1975-09-17

  • 分类号A61K9/00;A61K31/505;

  • 国家 FR

  • 入库时间 2022-08-22 21:46:46

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号